# Kiora Pharmaceuticals Inc: Form 8-K, filed Apr 26, 2022

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2022-04-26
- Accepted by EDGAR: Apr 26, 2022, 06:51 ET
- Period: 2022-04-21
- Accession: 0001104659-22-049935
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922049935/tm2213276d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000110465922049935/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000110465922049935/tm2213276d1_8k.htm

Filed Apr 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-049935. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
